ECMO during combined heart-kidney transplantation: A case report

Authors

Shai M Chazin
Michael A Bresticker, Advocate Aurora HealthFollow
Darshika Chhabra, Advocate Aurora HealthFollow
Deepak Mital, Advocate Aurora HealthFollow
Chaitanya R. Desai, Advocate Aurora HealthFollow
Douglas P. Slakey, Advocate Aurora HealthFollow

Recommended Citation

Chazin SM, Bresticker MA, Chhabra D, Mital D, Desai CR, Slakey DP. ECMO During Combined Heart-Kidney Transplantation: A Case Report. ASAIO J. 2020;66(2):e36-e38. doi: 10.1097/MAT.0000000000000995.

Affiliations

Department of Cardiovascular and Thoracic Surgery, Department of Transplant Nephrology, Department of Transplant Surgery, Department of Surgery, Advocate Christ Medical Center

Abstract

Combined heart-kidney transplantation (CHKT) is a therapy for a carefully selected subgroup of patients with concomitant heart and kidney failure. Discerning whether there is reversible or irreversible kidney disease is crucial to selection for CHKT versus heart transplant alone to optimize therapeutic value and organ allocation. Methods for determining extent of kidney disease include estimating glomerular filtration rate, creatinine clearance, kidney ultrasonography, and kidney biopsy. Additionally, the use of extracorporeal membrane oxygenation (ECMO) in the setting of CHKT only recently emerged as feasible. We present a case of a 69-year-old man with cardiogenic shock who was placed on venoarterial-ECMO (VA-ECMO) following orthotopic heart transplant (OHT) due to severe mediastinal bleeding and remained on VA-ECMO during kidney transplant. To our knowledge, this is the second report of a patient undergoing kidney transplant while on VA-ECMO following OHT.

Document Type

Case Report

PubMed ID

31385822